Literature DB >> 24920975

One and the same.

Ryan T Fitzgerald1.   

Abstract

Year:  2013        PMID： 24920975      PMCID： PMC4002185     

Source DB:  PubMed          Journal:  Rev Obstet Gynecol        ISSN： 1941-2797


× No keyword cloud information.
  11 in total

Review 1.  Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

Review 2.  Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-10       Impact factor: 3.825

3.  Atypical posterior reversible encephalopathy syndrome associated with chemotherapy with Bevacizumab, Gemcitabine and Cisplatin.

Authors:  R Dersch; O Stich; K Goller; S Meckel; F Dechent; S Doostkam; C Weiller; J Bardutzky
Journal:  J Neurol       Date:  2013-02-21       Impact factor: 4.849

Review 4.  Clinical features and outcomes of posterior reversible encephalopathy syndrome following bevacizumab treatment.

Authors:  R C S Seet; A A Rabinstein
Journal:  QJM       Date:  2011-08-24

5.  Reversible posterior leukoencephalopathy syndrome associated with concurrent bevacizumab, gemcitabine, and oxaliplatin for cholangiocarcinoma.

Authors:  Yongen Chang; Gilbert Mbeo; Susan J Littman
Journal:  J Gastrointest Cancer       Date:  2012-09

6.  Posterior reversible encephalopathy syndrome (PRES) with immune system activation, VEGF up-regulation, and cerebral amyloid angiopathy.

Authors:  Julia Kofler; Walter S Bartynski; Thomas Q Reynolds; Frank S Lieberman; Geoffrey H Murdoch; Ronald L Hamilton
Journal:  J Comput Assist Tomogr       Date:  2011 Jan-Feb       Impact factor: 1.826

7.  Reversible encephalopathy after cardiac transplantation: histologic evidence of endothelial activation, T-cell specific trafficking, and vascular endothelial growth factor expression.

Authors:  C Horbinski; W S Bartynski; E Carson-Walter; R L Hamilton; H P Tan; S Cheng
Journal:  AJNR Am J Neuroradiol       Date:  2008-10-14       Impact factor: 3.825

Review 8.  Vascular biology of preeclampsia.

Authors:  L Myatt; R P Webster
Journal:  J Thromb Haemost       Date:  2009-03       Impact factor: 5.824

9.  Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome.

Authors:  W S Bartynski; J F Boardman
Journal:  AJNR Am J Neuroradiol       Date:  2007-12-13       Impact factor: 3.825

10.  Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia.

Authors:  Justin Brewer; Michelle Y Owens; Kedra Wallace; Amanda A Reeves; Rachael Morris; Majid Khan; Babbette LaMarca; James N Martin
Journal:  Am J Obstet Gynecol       Date:  2013-02-07       Impact factor: 8.661
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.